The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 study on the efficacy and safety of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 and bevacizumab in newly diagnosed metastatic colorectal carcinoma.
 
Tariq Arshad
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion
Travel, Accommodations, Expenses - Bexion
Other Relationship - Bexion
 
Michael Gazda
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion
Travel, Accommodations, Expenses - Bexion
 
Gilles Tapolsky
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion
Travel, Accommodations, Expenses - Bexion
 
Jim Beach
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion
Travel, Accommodations, Expenses - Bexion
 
Daniel Flora
Employment - Medpace
Other Relationship - Bexion
 
Reema Patel
No Relationships to Disclose
 
Fa Chyi Lee
No Relationships to Disclose
 
Douglas Flora
Employment - St. Elizabeth Healthcare
Stock and Other Ownership Interests - Azra AI
Consulting or Advisory Role - Azra AI; Haystack MRD
 
Davendra Sohal
Consulting or Advisory Role - AADi; AstraZeneca/MedImmune; Bayer; Elevar Therapeutics; Regeneron; Totus Medicines; TransThera Sciences (Nanjing), Inc.; Valar Labs
Speakers' Bureau - AstraZeneca; Incyte; Seagen
Research Funding - Ability Pharma (Inst); Amgen (Inst); Apexigen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bexion (Inst); Bristol-Myers Squibb (Inst); FibroGen (Inst); Genentech (Inst); Hengrui Therapeutics (Inst); Merck (Inst); Mirati Therapeutics (Inst); NextCure (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Triumvira Immunologics, Inc (Inst)
Travel, Accommodations, Expenses - Ability Pharma
 
Saima Sharif
Research Funding - GlaxoSmithKline
 
Ki Chung
Consulting or Advisory Role - AstraZeneca; Castle Biosciences; Jazz Pharmaceuticals; Spring works
Research Funding - epizyme (Inst); MedImmune (Inst)
 
John Villano
Consulting or Advisory Role - SERVIER
 
Vivek Sharma
No Relationships to Disclose
 
Julie Anne Gemmill
No Relationships to Disclose
 
Agustin Pimentel
No Relationships to Disclose
 
Nashat Gabrail
Consulting or Advisory Role - Celgene; Chemiocare
Speakers' Bureau - Janssen Oncology; Janssen Oncology; Janssen Oncology; Karyopharm Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical; Tesaro/GSK
Research Funding - Amgen (Inst); Bayer (Inst); Chemiocare (Inst); Chemiocare (Inst); Kartos Therapeutics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Oncology Supply
 
Darryl Outlaw
No Relationships to Disclose
 
Ari Baron
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol-Myers Squibb
 
Brian Boulmay
No Relationships to Disclose